InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+14.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Hayes Christopher G., Directeur Juridique. Insider active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 11 disclosures have been logged. Split: 3 buys · 4 sells. Total volume traded: €323k. Activity tracked since 4 June 2021. The latest transaction was disclosed on 17 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hayes Christopher G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
4,315 shares@ US$0.650.8% of flowCommon StockSEC:0001415889-25-008505:0
150,000 shares0Common StockSEC:0001415889-25-003232:0
26,183 shares@ US$2.6618.2% of flowCommon StockSEC:0001415889-24-022427:0
21,649 shares@ US$7.0640.9% of flowCommon StockSEC:0001415889-24-019970:0
40,000 shares0Common StockSEC:0001415889-24-008543:0
22,141 shares@ US$2.9317.7% of flowCommon StockSEC:0001209191-23-055527:0
75,000 shares0Common StockSEC:0001209191-23-047521:0
100,000 shares0Common StockSEC:0001209191-23-043306:0
7,500 shares@ US$3.407.4% of flowCommon StockSEC:0001209191-22-041835:0
Canonical exit: 9 Oct 2022 (T+90)
5,714 shares@ US$2.103.4% of flowCommon StockSEC:0001209191-22-040616:0
Canonical exit: 3 Oct 2022 (T+90)
2,500 shares@ US$9.796.2% of flowCommon StockSEC:0001209191-21-038481:0
Canonical exit: 2 Sept 2021 (T+90)
11 of 11 declarations
About Hayes Christopher G.
Hayes Christopher G. is Directeur Juridique at Verrica Pharmaceuticals Inc. (CHIEF LEGAL OFFICER, XNAS). Across 11 filings in total, the 11 sampled recent filings span from 2021-06-07 to 2025-03-18, with EUR 57,250 in buys and EUR 265,931 in sells, and the most frequent transaction nature being sale.
